Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Korea’s Ilyang Pharm, LegoChem Boosted By Anti-Cancer Therapy Deals

This article was originally published in PharmAsia News

Executive Summary

South Korean pharmas advance in the oncology space as Ilyang Pharm lets Colombia's Biopas sell its novel leukemia therapy Supect in 10 Latin American countries, while LegoChem Biosciences links with Fosun Pharma for development and commercialization of its antibody-drug conjugate as an anticancer therapy for the Greater China region.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts